Health Trials

Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer

ConditionsLevonorgestrelIntrauterine SystemsPreventionEndometrial Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorM.D. Anderson Cancer Center

About this trial

To develop an educational tool to help patients and healthcare professionals make informed decisions about endometrial cancer and available prevention options for it (such as the use of a levonorgestrel-releasing intrauterine system \[LNG-IUS\]).

Eligibility criteria

Qualifiers

Unaffected women

Must be at least 18 years old

Must read and speak English or Spanish

Must be premenopausal

Disqualifiers

N/A

Trial design

Treatments tested in this trial

  • Survey using a questionnaire

Treatment groups

270 Participants
are divided into 2 treatment groups

Sponsors and collaborators

M.D. Anderson Cancer Center

Lead sponsor

Cancer Prevention Research Institute of Texas

Collaborator

Source ClinicalTrials.gov